Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India

Ítems similars

• Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
  per: Gersh, Felice L.
  Publicat: (2020)
• Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland
  per: Wan Md Adnan, Wan A H, et al.
  Publicat: (2011)
• In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
  per: Sanchis-Gomar, Fabian, et al.
  Publicat: (2020)
• Preparation, validation and user-testing of pictogram-based patient information leaflets for hemodialysis patients
  per: Mateti, Uday Venkat, et al.
  Publicat: (2015)
• Pattern of Angiotensin-Converting Enzyme Inhibitors Induced Adverse Drug Reactions in South Indian Teaching Hospital
  per: Mateti, Uday Venkat, et al.
  Publicat: (2012)